Fulcrum Therapeutics Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

4.38

0.53 (13.77%)

At close: May 01, 2025, 3:59 PM

4.25

-3.01%

After-hours: May 01, 2025, 07:37 PM EDT

Fulcrum Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	58.21M	25.56M	35.1M	35.41M	57.05M	96.71M	72.8M	407K
Short-Term Investments	182.81M	210.66M	167.82M	182.75M	55.86M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.09M	1.09M	1.09M	1.09M	1.09M	n/a
Other Long-Term Assets	1.21M	3.1M	2.1M	542K	7.17M	-78.68M	38K	60K
Receivables	3.34M	2.25M	1.08M	4.11M	2.71M	111K	501K	39K
Inventory	n/a	n/a	-852K	-473K	-2.78M	2.98M	559K	734K
Other Current Assets	n/a	n/a	n/a	n/a	74K	284K	238K	248K
Total Current Assets	249.92M	242.2M	207.52M	226M	112.91M	100.08M	74.09M	1.34M
Property-Plant & Equipment	9.58M	12.39M	15.97M	7.37M	8.4M	87.94M	10.55M	2.94M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.79M	15.49M	19.17M	9M	16.66M	10.36M	11.68M	3M
Total Assets	260.72M	257.69M	226.69M	235M	129.58M	110.44M	85.77M	4.34M
Account Payables	1.16M	2.76M	3.64M	4.79M	4.08M	2.19M	1.26M	1.67M
Deferred Revenue	n/a	n/a	934K	4.71M	14.91M	3.99M	2.8M	n/a
Short-Term Debt	n/a	n/a	2.6M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	463K	396K	2.74M	4.71M	4.79M	3.68M	781K	20K
Total Current Liabilities	11.04M	13.68M	16.73M	19.2M	26.73M	12.14M	4.23M	2.79M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.59M
Other Long-Term Liabilities	197K	197K	197K	4.26M	4.7M	5.13M	5.54M	-34.35M
Total Long-Term Liabilities	6.64M	8.83M	11.02M	4.26M	7.67M	11.15M	5.54M	233K
Total Liabilities	17.68M	22.5M	27.74M	23.46M	34.4M	23.29M	9.77M	3.02M
Total Debt	8.63M	10.82M	13.42M	n/a	17K	50K	46K	34.59M
Common Stock	54K	62K	52K	41K	28K	23K	16K	1K
Retained Earnings	-519.4M	-509.67M	-412.34M	-302.47M	-221.62M	-150.8M	-68.12M	-35.54M
Comprehensive Income	130K	-136K	-797K	-397K	-2K	-110.44M	-1.96M	-893K
Shareholders Equity	243.03M	235.19M	198.94M	211.54M	95.18M	87.15M	76M	1.32M
Total Investments	182.81M	210.66M	167.82M	182.75M	55.86M	1.09M	1.09M	n/a